REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 142 filers reported holding REPLIMUNE GROUP INC in Q2 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.5%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,001,319 | $69,690,627 | 39.05% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $48,722,526 | 6.06% |
| Redmile Group, LLC | 4,420,533 | $102,644,776 | 3.94% |
| Nan Fung Group Holdings Ltd | 184,739 | $4,289,640 | 2.74% |
| Altium Capital Management LP | 130,000 | $3,018,600 | 2.28% |
| BVF INC/IL | 2,143,036 | $49,761,296 | 1.39% |
| Ikarian Capital, LLC | 348,200 | $8,085,204 | 1.29% |
| Integral Health Asset Management, LLC | 445,000 | $10,332,900 | 1.28% |
| Camber Capital Management LP | 1,550,000 | $35,991 | 1.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 900,952 | $20,920,105 | 1.14% |
| EMERALD ADVISERS, LLC | 1,086,287 | $25,223,584 | 1.10% |
| SECTORAL ASSET MANAGEMENT INC | 238,541 | $5,538,922 | 0.92% |
| Ikarian Capital, LLC | 228,300 | $5,301,126 | 0.84% |
| Resolute Capital Asset Partners LLC | 43,977 | $1,021 | 0.73% |
| Baker Brothers Advisors | 4,578,280 | $106,307,662 | 0.62% |
| Frazier Life Sciences Management, L.P. | 386,762 | $8,980,614 | 0.54% |
| Sofinnova Investments, Inc. | 348,889 | $8,101,203 | 0.53% |
| MOODY ALDRICH PARTNERS LLC | 106,808 | $2,480,082 | 0.48% |
| Simplify Asset Management Inc. | 150,000 | $3,483,000 | 0.46% |
| BRAIDWELL LP | 487,520 | $11,320,214 | 0.37% |
External links
This page lists REPLIMUNE GROUP INC's shareholders in Q2 2023. To view REPLIMUNE GROUP INC's shareholder history, click here.